Greg LeMond, the celebrated American cyclist and three-time Tour de France champion, announced in June 2022 that he had been diagnosed with chronic myelogenous leukemia (CML). In a statement on his website, LeMond, then 60, shared: “I have been diagnosed with chronic myelogenous leukemia. Fortunately, it is a type of cancer that is treatable, and it is a type of leukemia that is not life-threatening or debilitating.”
LeMond’s revelation was met with widespread support from the cycling community and sports enthusiasts worldwide. Known for his resilience, LeMond overcame a near-fatal hunting accident in 1987, returning to win the Tour de France in 1989 and 1990.
Chronic myelogenous leukemia is a rare type of cancer that starts in certain blood-forming cells of the bone marrow. It typically progresses slowly and is often detected through routine blood tests before symptoms appear. Advancements in treatment have significantly improved the prognosis for CML patients, making it a manageable condition with appropriate medical care.
LeMond’s diagnosis highlights the importance of regular health check-ups and early detection. His openness about his condition serves as an inspiration, demonstrating that with timely intervention and a positive outlook, individuals can continue to lead fulfilling lives despite health challenges.
As of January 2025, there have been no public updates regarding LeMond’s health since his initial announcement in June 2022. Fans and the cycling community continue to send their best wishes, hoping for his well-being and looking forward to any future updates.
Leave a Reply